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Objective.  The aim of this study is to obtain helpful information for an effective 
antimicrobial therapy against orofacial odontogenic infections; such information 
would be obtained from recent bacteriologic features and antimicrobial susceptibility 
data.  
Study design.  The bacteriology and antimicrobial susceptibility of major pathogens 
in 163 patients with orofacial odontogenic infections to seven antibiotics was 
examined.   
Results.  Mixed infection of strict anaerobes with facultative anaerobes (especially 
viridans streptococci) was observed most often in dentoalveolar infections, 
periodontitis, and pericoronitis.  Penicillin (penicillin G) was effective against 
almost all pathogens, although it did not work well against ß-lactamase-positive 
Prevotella.  Cefmetazole was effective against all test pathogens.  Erythromycin 
was ineffective against viridans streptococci and most Fusobacterium.  Clindamycin 
exerted a strong antimicrobial activity on anaerobes.  Minocycline was effective 
against almost all of the test pathogens.  The antimicrobial activity of levofloxacin 
against viridans streptococci was not strong.  
Conclusions.  An antibiotic that possesses antimicrobial activity against both 
viridans streptococci and oral anaerobes should be suitable for treatment of 
dentoalveolar infection, periodontitis, and pericoronitis.  Penicillin remains effective 
as an antimicrobial against most major pathogens in orofacial odontogenic infections.  
Cefmetazole, clindamycin, and minocycline may be effective against most pathogens, 
including penicillin-unsusceptible bacteria. 
 2
Although numerous patients suffer from orofacial odontogenic infections, many of 
these infections can be managed without the use of antibiotics, e.g., by tooth 



























However, when an acute bacterial infection has progressed or antimicrobial therapy 
might be of benefit to patients, antibiotics are prescribed.1-6  When antibiotics are 
prescribed for the treatment of orofacial odontogenic infections, clinicians should 
choose them on a case-specific basis, and the choice should be based on several 
factors, e.g., laboratory data, patient’s health, age, allergies, drug absorption and 
distribution ability, and plasma levels. 1-6  Penetration and metabolism of the drug, 
type or location of the infection, previous use of antibiotics, and cost are other factors 
to be considered.1-6  The laboratory data regarding bacteriology and antimicrobial 
susceptibility is crucial information for the clinician considering the administration of 
the antimicrobial therapy.3,6,7-9  However, it may take several days or even longer to 
obtain such data.  Hence, antibiotics may be chosen empirically.  ß-Lactam 
antibiotics, especially penicillins, have traditionally been recommended as a first-line 
antibiotic because they work well against most causative bacteria and because 
penicillins have a low incidence of side effects.1-6  Furthermore, such medicines are 
relatively inexpensive.3,6  Some studies have suggested that the antimicrobial 
activity of penicillins has decreased against the causative bacteria related to orofacial 
odontogenic infections, such as streptococci and oral anaerobes.1,4-6  However, the 
debate continues over whether penicillins remain adequate as the first-line antibiotics 
of choice.1-7  Alternative regimens of antimicrobial therapy have been proposed for 
patients with penicillin allergies, or in cases in which penicillin therapy has failed.2-6  
In addition, the properties of each antibiotic therapy should be considered based on 



























  In the present study, the bacteriological features of orofacial odontogenic infections 
and the antimicrobial susceptibility of pathogens recently isolated at our hospital were 
determined.  Based on the data, we estimated the antimicrobial effectiveness of each 
antibiotic as regards the treatment of orofacial odontogenic infections. 
 
MATERIALS AND METHODS 
Patients 
  The case histories of a total of 163 patients with obstructed abscesses caused by 
orofacial odontogenic infections were investigated.  The patients were treated at our 
hospital between April 1991 and March 1997.  Patients who required intensive 
medical care (e.g., cases with diabetes mellitus, rheumatoid arthritis, respiratory tract 
infections, leukaemia) were excluded.  The following orofacial odontogenic 
infections were studied: dentoalveolar infections (128 cases), periodontitis (24 cases), 
and pericoronitis (11 cases).  Before pus collection, at our hospital, other hospitals, 
or private practices, ninety-one patients had received antibiotics (ß-lactam antibiotics) 
during the course of the infection. 
All subjects in this study gave their informed consent to participate.  
 
Bacteriologic examination 
  To identify causative agents, pus specimens were sampled.  The specimens were 
collected from the abscesses with an 18-gauge needle.  The specimens were placed 
in anaerobic transport devices (Seed Tube; Eiken, Tokyo, Japan) and were 
immediately transported to the laboratory.  
  When the specimens reached the laboratory, bacteriologic examination was 
performed immediately as follows: a portion of each specimen was incubated on 
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2, 10% H2, and 85% N2 at 37°C for 78 h.  At the same time, a portion of the 
specimen was also incubated on Brucella HK agars with 5% sheep blood in an aerobic 
atmosphere and in an atmosphere of 10% CO2, 20% H2, and 70% N2 at 37°C for 48 h.  
Incubation continued for at least seven days, even in the absence of bacterial growth.  
Aerobic and micro-aerophilic bacteria were identified using conventional 
methods.10,11  Anaerobic bacteria were identified using Rap ID ANA II (Innovative 
Diagnostic System, Norcross, GA).  In addition to the test, gas liquid 
chromatography was performed when needed to identify the bacteria.11,12  After the 
bacteriologic examination, bacterial strains were stored in 10% skim milk 




  Antibiotics were obtained from their manufacturers as laboratory powders; each 
antibiotic was of a defined potency: penicillin G (Banyu, Tokyo, Japan), cefazolin 
(Fujisawa, Osaka, Japan), cefmetazole (Sankyo, Tokyo, Japan), erythromycin 
(Shionogi, Osaka, Japan), clindamycin (Pharmacia & Upjohn, North Peapack, NJ), 
minocycline (Takeda, Osaka, Japan), and levofloxacin (Dai-ichi, Tokyo, Japan). 
  All minimum inhibitory concentrations (MICs) were determined by the agar 
dilution method recommended by the National Committee for Clinical Laboratory 
Standards (NCCLS).7,8  The MICs of streptococci were determined using 
Mueller-Hinton agar (Becton Dickinson) with 5% sheep blood in an atmosphere of 
10% CO2, 20% H2, and 70% N2 at 37°C for 24 h.7  A reference strain of 
Streptococcus pneumoniae ATCC 49619 was used as the control in each test.7  The 
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MICs of anaerobes were determined using Brucella HK agar with 5% sheep blood in 


























2, 10% H2, and 85% N2 at 37°C for 48 h.8  Reference 
strains of Bacteroides fragilis ATCC 25285 and Bacteroides thetaiotaomicron ATCC 
29741 were used as controls in each test.8  In the present study, the susceptibility 
breakpoints against viridans streptococci and anaerobes were determined by NCCLS 
criteria.7-9  Since the breakpoints of cefazolin, minocycline, and levofloxacin against 
anaerobes have not been determined by the NCCLS, we determined them based on the 
breakpoints of other similar antibiotics, i.e., those which resemble them in structure 
and pharmacokinetics.  The breakpoints against viridans streptococci were as 
follows: penicillin G, ≤0.12µg/ml; cefazolin, ≤8µg/ml; cefmetazole, ≤8µg/ml; 
erythromycin and clindamycin, ≤0.25µg/ml; minocycline, ≤2µg/ml; levofloxacin, 
≤2µg/ml.  The breakpoints against strict anaerobes were as follow: penicillin G, 
≤0.5µg/ml; cefazolin, ≤8µg/ml; cefmetazole, ≤16µg/ml; clindamycin, ≤2µg/ml; 
minocycline, ≤4µg/ml; levofloxacin, ≤2µg/ml.  As the breakpoint of erythromycin 
against strict anaerobes has not been determined by the NCCLS, it was determined for 
the present study to be ≤4µg/ml, according to a report by Spangler et al.13
 
ß-Lactamase test 
  Nitrocefin disks (Cefinase disk; Becton Dickinson) were inoculated as described 
above with a small portion of growth from the Brucella blood agar plates and the 
disks were observed for a change in colour from yellow to red.6,14  Bacteroides 
fragilis ATCC 25285 was included as a positive control.14
 
Correlation of antimicrobial activity of penicillin G with that of other antibiotics 



























not grow at the breakpoint concentration of penicillin G, the strain was defined as 
penicillin G-susceptible (PS).  In contrast, when the strain grew at the breakpoint 
concentration, the strain was defined as penicillin G-unsusceptible (PU).  The MIC 
values and the susceptibility rates of PS strains against antibiotics were compared 
with those of PU strains.   
 
Statistical analysis 
Statistical comparisons of the susceptibility rates and incidence of 




A total of 664 strains were isolated from the test cases.  Viridans streptococci, 
Peptostreptococcus, Gemella, pigmented and nonpigmented Prevotella, 
Porphyromonas, and Fusobacterium were predominant (Table I).  Fundamentally, 
there was no difference in the bacteriologic data as regards the type of infection 
(dentoalveolar infections, periodontitis, and pericoronitis) and in presence or absence 
of past administration of antibiotics (data not shown).  Antimicrobial susceptibilities 
were determined in viridans streptococci, Peptostreptococcus, pigmented and 
nonpigmented Prevotella, Porphyromonas, and Fusobacterium.  
 
Relation between the isolation flora and type of the infection 
  Most of the dentoalveolar infections, periodontitis, and pericoronitis were mixed 
infections involving a number of bacterial species (Table II).  Average numbers of 



























pericoronitis were 4.1 (range 1-10), 4.3 (range 2-7), and 3.7 (range 2-6), respectively.  
Anaerobes were isolated from 90.6% to 100% in the three types of infection.  Most 
of the facultative anaerobes isolated from the three types of infection were viridans 
streptococci.  Isolation flora in all three types of infection were similar to one 
another, although aerobes and facultative anaerobes were found more frequently in 
the dentoalveolar infections than in cases of periodontitis and pericoronitis (Table II).  
More than half of each odontogenic infection had mixed flora including both strict 
anaerobes and facultative anaerobes; this was especially the case with viridans 
streptococci.   
 
Susceptibility to penicillin G 
  Viridans streptococci showed a susceptibility rate of 77% and 0.25µg/ml of MIC90 
value to penicillin G, suggesting that penicillin G would work well to eradicate 
viridans streptococci (Table III).  Peptostreptococcus, Porphyromonas, and 
Fusobacterium showed 86%, 100%, and 89% susceptibility rates, respectively, and 
their MIC90 values were low.  Although 72% of pigmented and 82% of 
nonpigmented Prevotella were susceptible to penicillin G, their MIC90 values were 
very high (≥16µg/ml).  Eighty-five percent (22 of 26) of the PU strains of pigmented 
Prevotella were ß-lactamase positive, whereas 0% (0 of 67) of the PS strains were 
ß-lactamase positive; these results were significant (P< .0001).  In nonpigmented 
Prevotella, all PU strains produced ß-lactamase, but none of the PS strains produced 
it (P< .0001). 
 
Correlation of the susceptibility to penicillin G with that to the other antibiotics 
  Cefazolin worked well against viridans streptococci, Peptostreptococcus, 
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Porphyromonas, and Fusobacterium (Table IV).  However, PU strains of pigmented 


























50 and MIC90 values, and 
significantly smaller susceptibility rates than did the PS strains (P< .0001)(Table IV).  
All cefazolin-unsusceptible strains (MIC, ≥16µg/ml) of pigmented and nonpigmented 
Prevotella produced ß-lactamase.  Cefmetazole was also effective against viridans 
streptococci, Peptostreptococcus, Porphyromonas, and Fusobacterium (Table V).  
Moreover, cefmetazole worked well against both PS and PU strains of pigmented and 
nonpigmented Prevotella (Table V).  
  Only 55% of the PS viridans streptococci were susceptible to erythromycin.  
Surprisingly, PU viridans streptococci was not susceptible to erythromycin at all, and 
this susceptibility rate was significantly lower than that of the PS strains 
(P< .0005)(Table VI).  The MIC50 and MIC90 values of PS and PU strains of 
Fusobacterium were very high.  Erythromycin was effective against only 29% and 
0% of PS and PU Fusobacterium, respectively. 
  In viridans streptococci, clindamycin was effective against 54% of the PS strains 
and 0% of the PU strains, respectively (Table VII).  However, the MIC90 values of 
clindamycin against both strains were the same, namely, 0.5µg/ml.  Clindamycin 
showed a quite strong antimicrobial activity against all strict anaerobes tested.  In 
particular, clindamycin worked very well against pigmented and nonpigmented 
Prevotella, regardless of their susceptibilities to penicillin G (Table VII).   
  Although the antimicrobial activity of minocycline against the PU strains of 
pigmented Prevotella was decreased, minocycline was effective against most of the 
bacteria tested (Table VIII).   
  Only 56% of PS viridans streptococci were susceptible to levofloxacin (Table IX), 
and the PU viridans streptococci showed significantly smaller susceptible rate (25%) 
 9
than PS strains (P< .005).  Levofloxacin was effective against strict anaerobes, 
although its antimicrobial activity against Fusobacterium was weaker than when in 




























Many investigators have demonstrated that viridans streptococci, 
Peptostreptococcus, Prevotella, Porphyromonas, and Fusobacterium are frequently 
isolated from orofacial odontogenic infections.1-6,15,16  Our bacteriologic data was in 
good agreement with that of these previous studies.  The present study was analyzed 
with respect to isolation flora and type of infection.  Most of patients had mixed 
infections, regardless of the type of infection that had initially been diagnosed (Table 
II).  The average number of isolates per abscess was approximately four strains, 
which was a finding in agreement with those of other reports.15,16  Only small 
differences in the isolated flora were observed among these types of infections (Table 
II).  Strict anaerobes were found in almost of all of the patients, and these were often 
accompanied with facultative anaerobes, especially streptococci, regardless of the 
type of infection.  It has been reported that a combination of anaerobic gram-positive 
cocci and anaerobic gram-negative rods were found frequently in dental root canal 
infections.17,18  In the present study, the combination of strict anaerobic 
gram-positive cocci and strict anaerobic gram-negative rods was also found somewhat 
frequently in all types of infection examined.  The present study suggests that the 
combination may be associated with all kinds of odontogenic infections.  Further 
study of individual pathogens in various bacterial combinations is required to 
elucidate the role of these pathogens in the occurrence and prognosis of odontogenic 
infection.  
 10
Determination of the respective breakpoints may be important to analyze 


























7-9  In general, 
breakpoints are determined based on data concerning the clinical outcome, the 
pharmacology of the agents, e.g., tissue and serum concentrations, degree of 
protein-binding, distribution of susceptibility of bacteria to agents, etc.7  However, 
the specific breakpoints against pathogens in odontogenic infections have not been 
established.  When antibiotics are administered, concentrations of antibiotics in oral 
and maxillofacial regions are much smaller than those found in serum samples.19-21  
In addition, the respective concentrations of antibiotic vary according to oral and 
maxillofacial regions; concentrations at the mandibular bone are lower than those in 
the dental alveolar serum, dental follicle, and gingiva.19-21  Thus, it may be difficult 
to determine the special breakpoints for orofacial odontogenic infections.  In the 
present study, the susceptibility breakpoints were determined by NCCLS criteria,7-9 
which are widely used in various bacterial studies.  However, NCCLS breakpoints 
might be too strict for some of test antibiotics because the breakpoints are below the 
typical serum or tissue concentrations of the antibiotics.  The bacterial strains that 
were determined to be unsusceptible to certain antibiotics according to the present 
criteria might actually be clinically susceptible to those antibiotics, as they may be 
affected by other factors, such as infection site or dosage.  
  The effectiveness of penicillins against viridans streptococci and 
ß-lactamase-producing anaerobic gram-negative rods has been previously debated in 
the literatures.1-6,22  In the present study, the growth of 90% of viridans streptococci 
was inhibited at 0.25µg/ml penicillin G despite a susceptibility rate of 77% (Table III), 
indicating that penicillins remain reasonably effective against viridans streptococci.  



























susceptible to penicillin G at the tested concentrations, respectively, and their MIC90 
values were high (≥16µg/ml).  Notably, PU strains of pigmented and nonpigmented 
Prevotella were shown to produce ß-lactamase more frequently than did PS strains 
(P< .0001), indicating that the resistance of Prevotella against penicillin G is 
correlated with ß-lactamase production.  It is important that, despite this resistance, 
more than 70% of pigmented and nonpigmented Prevotella were susceptible to 
penicillin G at the tested concentrations.   
  Cephalosporins should generally not be prescribed for patients who have immediate 
hypersensitivity reactions to penicillin, because some of these patients may also be 
allergic to several other ß-lactam antibiotics.23  On the other hand, the 
cephalosporins are bactericidal and have few side effects; some of them have broader 
antimicrobial spectra and show stronger bactericidal activity against the pathogens 
specific to orofacial odontogenic infections.23  In the present study, cefazolin and 
cefmetazole were shown to exert a great antimicrobial activity against the viridans 
streptococci, Peptostreptococcus, Porphyromonas, and Fusobacterium (Tables IV and 
V).  Interestingly, the PU strains of pigmented and nonpigmented Prevotella, 
compared with the PS strains, were more resistant to cefazolin (P< .0001).  In 
contrast, cefmetazole was active against all test bacteria.  Cefazolin belongs to the 
first-generation cephalosporins, and is vulnerable to ß-lactamase,23 while the stability 
of cefmetazole in response to ß-lactamase has been confirmed.23,24  
ß-Lactamase-stable cephalosporins, including cefmetazole, are effective against 
infections.  However, these antibiotics are expensive.6  In addition, some of these 
cephalosporins, including cefmetazole, are intravenously administered antibiotics.23  
The high cost or the inconvenience of intravenous administration of antibiotics may 
preclude wide use against odontogenic infections.  
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1-6  However, it has been noted that erythromycin is not effective against 
Fusobacterium.5,25  Our findings confirmed the poor antimicrobial activity of 
erythromycin against Fusobacterium (Table VI).  Furthermore, erythromycin was not 
effective against viridans streptococci.  In particular, erythromycin showed only 
weak antimicrobial activity against the PU strains.  It has been demonstrated that 
Streptococcus and Fusobacterium are more frequently isolated from severe 
odontogenic infections than from milder infections.26  The results of the present 
study suggest that erythromycin may be effective against mild or moderate infections 
in people with penicillin allergies, but it may not be suitable in cases of more severe 
infection.  In addition, even in cases in which penicillin therapy fails, erythromycin 
may not be recommended. 
  Clindamycin is a powerful antibiotic against strict anaerobes including 
ß-lactamase-producing bacteria.1-5,27  Our findings confirmed that clindamycin is a 
powerful agent against strict anaerobes, particularly against pigmented and 
nonpigmented Prevotella (Table VII).  In the present study, the susceptibility rates of 
viridans streptococci to clindamycin, according to the breakpoint determined by 
NCCLS,7 were low.  However, growth of most viridans streptococci (both the PS and 
the PU strains) was inhibited by 0.5µg/ml clindamycin.  Clindamycin produces high 
alveolar concentrations,3 and bactericidal activity is achieved clinically with the usual 
recommended dose.2  In addition, clindamycin might increase host defence 
potential,28-30 and inhibit ß-lactamase production.31  Thus, clindamycin would be 
effective in the treatment of infections.  However, because of its propensity to cause 
antibiotic-associated colitis, it has not been widely used in more routine cases of mild 



























infections, or in cases in which penicillin therapy has failed.   
  Many studies have indicated widespread resistance to tetracyclines.1,3  In the 
present study, although the antimicrobial activity against the PU pigmented Prevotella 
was slightly decreased, minocycline was effective against all test bacteria (Table VIII).  
Although minocycline is bacteriostatic, it exerts greater antimicrobial activity against 
strict anaerobic bacteria than that of tetracycline or other parent compounds.3,32  In 
cases in which infection is mild or moderate, minocycline may be effective, especially 
for patients allergic to penicillin or in cases of penicillin therapy failure.  However, 
when minocycline is prescribed, an attention should be paid to its adverse effects, e.g., 
gastrointestinal upset, photosensitivity, tooth discoloration.2,3
  The present study demonstrated that less than 60% of viridans streptococci were 
susceptible to levofloxacin (Table IX), a fluoroquinolone, which was not as effective 
against strict anaerobic bacteria as the other test antibiotics.  In addition, 
fluoroquinolones are less cost-effective than the other antibiotics.  Thus, the present 
results do not suggest that fluoroquinolones be used for the treatment of such 
infections.  
In conclusion, viridans streptococci, anaerobic gram-positive cocci, and anaerobic 
gram-negative rods were isolated frequently from orofacial odontogenic infections.  
Mixed infection of strict anaerobes with facultative anaerobes, especially viridans 
streptococci, was predominant in odontogenic infections regardless of the type of 
infection.  When orofacial odontogenic infections are treated with antibiotics, an 
antimicrobial spectrum against both viridans streptococci and oral strict anaerobes 
may be required.  Penicillin still possesses powerful antimicrobial activity against 
major pathogens in orofacial odontogenic infections.  However, 















results suggest that cefazolin may not have more advantages than penicillin, but 
cefmetazole may be more effective against infection than penicillin because 
cefmetazole possesses strong antimicrobial activity against ß-lactamase-producing 
bacteria.  Moreover, clindamycin may be effective in the treatment of orofacial 
odontogenic infections.  Minocycline also demonstrated good antimicrobial activity.  
However, the findings of the present study indicate that erythromycin and 
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Aerobes AnaerobesNumber of isolates
Number of 
isolates









































Number of cases (Proportion, %)
Isolated flora
AGPC & AGNR *
AGNR *
AGPC *
AGPC & AGNR & Facultative anaerobes *

















AGNR & Facultative anaerobes 24(18.8) 1  (9.1)4(16.7)
Strict anaerobes & Aerobes 1  (0.8) 1   (9.1)0
AO & Facultative anaerobes 5  (3.9) 01  (4.2)
5 (20.8)
16 (66.7)









AGPC, Strict anaerobic gram-positive cocci; AGNR, Strict anaerobic gram-negative rods; AO, strict anaerobes other than 
AGPC and AGNR. 
*A few cases contained AO. 







Facultative anaerobes alone 5  (3.9) 01  (4.2)
Facultative anaerobes & Aerobes 3  (2.3) 00
Aerobes alone 0 00



















































































* Patients who had not received any antibiotics before specimen collection.
† Patients who had received antibiotics before specimen collection.
Aerobes Anaerobes
Number of isolates
Antibiotics (-)* Antibiotics (+)†
Number of isolates
Antibiotics (-)* Antibiotics (+) †
(91 cases)(72 cases) (91 cases)(72 cases)











≤0.015 - 0.5 0.12 0.25 77
≤0.015 - 4 ≤0.015 2 86
≤0.015 - 64 ≤0.015 32 72
≤0.015 - 64 ≤0.015 16 82
≤0.015 - 2 0.03 1 89
Table III. Antimicrobial susceptibility to penicillin G 
Porphyromonas ≤0.015 - 0.5 0.03 0.12 100
*50% and 90%, MIC50 and MIC90, respectively.
†The breakpoints of penicillin G  against viridans streptococci and 













2 32 73 §
0.06 1 100
16 64 30 §





* PS, penicillin G susceptible-strains; PU, penicillin G unsusceptible-strains. 
All test Porphyromonas strains were susceptible to penicillin G.
† 50% and 90% indicate MIC50 and MIC90, respectively.
‡ The breakpoints of cefazolin against viridans streptococci and anaerobes 
are 8 µg/ml. 
§P< .0001. Statistically significant difference from that of PS strains.































0.06 - 0.5 0.06 0.06 100





















*,† See Table IV.
‡The breakpoints of cefmetazole against viridans streptococci and anaerobes 
are 8 µg/ml and 16 µg/ml, respectively. 
Table V. Antimicrobial susceptibility to cefmetazole












































0.5 32 77 §
0.5 32 89
0.06 32 80




0.5 2 0 §
*,† See Table IV.
‡ The breakpoints of erythromycin against viridans streptococci and anaerobes
are 0.25 µg/ml and 4 µg/ml, respectively.
§ P< .0005. Statistically significant difference from that of PS strains.
Table VI. Antimicrobial susceptibility to erythromycin




















































*,† See Table IV.
‡ The breakpoints of clindamycin against viridans streptococci and anaerobes
are 0.25 µg/ml and 2 µg/ml, respectively.
§ P< .0001. Statistically significant difference from that of PS strains.
































































*,† See Table IV.
‡The breakpoints of minocycline against viridans streptococci and anaerobes 
are 2 µg/ml and 4 µg/ml, respectively.

































































*,† See Table IV.
‡ The breakpoints of levofloxacin against viridans streptococci and anaerobes 
are 2 µg/ml.
§P< .005. Statistically significant difference from that of PS strains.
Table IX. Antimicrobial susceptibility to levofloxacin
Porphyromonas PS 91
Fusobacterium PS
PU
107
32
90
15
67
26
46
10
35
80
10
4 76
≤0.015 - 64
≤0.015 - 8
≤0.015 - 8
≤0.015 - 8
0.25 - 32
≤0.015 - 32
0.25 - 32
1 - 16
≤0.015 - 16
≤0.015 - 4
0.5 - 4
2
0.5
0.06
0.25
1
0.5
2
4
0.25
1
0.5 4 70
1
Type 
of
strain*
Number
of 
strain
